Cronyxin 50 mg/g Oral paste for horses
Cronyxin 50 mg/g Oral paste for horses
Authorised
- Flunixin meglumine
Product identification
Medicine name:
Cronyxin 50 mg/g Oral paste for horses
Cronyxin 50 mg/g Pasta voor oraal gebruik
Cronyxin 50 mg/g Pâte orale
Cronyxin 50 mg/g Paste zum Einnehmen
Active substance:
- Flunixin meglumine
Target species:
-
Horse
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Flunixin meglumine83.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Oral paste
Withdrawal period by route of administration:
-
Oral use
-
Horse
-
Meat and offal15day
-
Milkno withdrawal periodNot authorised for use in animals producing milk for human consumption.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AG90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- (ID5) 396 gram(s): unspecified outer container with 12 Applicator (High Density PolyEthylene) each with 33 gram(s)
- (ID4) 198 gram(s): unspecified outer container with 6 Applicator (High Density PolyEthylene) each with 33 gram(s)
- (ID3) 99 gram(s): unspecified outer container with 3 Applicator (High Density PolyEthylene) each with 33 gram(s)
- (ID2) 66 gram(s): unspecified outer container with 2 Applicator (High Density PolyEthylene) each with 33 gram(s)
- (ID1) 33 gram(s): unspecified outer container with 1 Applicator (High Density PolyEthylene) with 33 gram(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Bimeda Animal Health Limited
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V538240
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0178/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Estonia
-
Finland
-
France
-
Ireland
-
Italy
-
Netherlands
-
Poland
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?:
